dobutamine and cardiovascular agents
dobutamine has been researched along with cardiovascular agents in 59 studies
Research
Studies (59)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 6 (10.17) | 18.7374 |
1990's | 13 (22.03) | 18.2507 |
2000's | 18 (30.51) | 29.6817 |
2010's | 19 (32.20) | 24.3611 |
2020's | 3 (5.08) | 2.80 |
Authors
Authors | Studies |
---|---|
Boudoulas, H; Leier, CV; Lewis, RP; Rittgers, SE; Weissler, AM | 1 |
Kambayashi, M; Miura, T; Murata, K; Oh, BH; Rockman, HA; Ross, J | 1 |
Annane, D; Bellissant, E; Depret, J; Richard, C; Teboul, JL; Thuillez, C | 1 |
Crowley, MR; Fineman, JR; Soifer, SJ | 1 |
Cramer, E; Frucht, U; Kunow, P | 1 |
McGuirk, SM; Muir, WW | 1 |
Benjamin, GC | 1 |
Khosropour, R; Lackner, F; Zimpfer, M | 1 |
Abou-Mohamed, G; Caldwell, RW; Ibrahim, TM; Tuttle, RR | 1 |
Abou-Mohamed, G; Caldwell, RW; Carrier, GO; Elmazar, MM; Tuttle, RR | 1 |
Faggiano, P; Ghizzoni, G; Lombardi, C; Rusconi, C; Sorgato, A; Spedini, C | 1 |
O'Brien, PD; Warltier, DC; Wynsen, JC | 1 |
Goldberg, D; Goldstein, S; Lesch, M; Levine, AB; Levine, TB; Narins, B | 1 |
Camarano, G; Goodman, NC; Ismail, S; Jayaweera, AR; Kaul, S; Sklenar, J | 1 |
Bigi, R | 1 |
Martin, JF; Omens, M; Woodruff, EA | 1 |
Sakamoto, T; Suzuki, A | 1 |
Cesario, AS; Donati, R; Gambelli, G; Mezzanotte, R; Pau, F; Pozzar, F; Schiavo, B | 1 |
Bartunek, J; de Bruyne, B; Heyndrickx, GR; Wijns, W | 1 |
Baraldo, M; Furlanut, M; Pea, F; Porreca, L | 1 |
Greyson, C; Lu, L; Schwartz, GG; Xu, Y | 1 |
Russell, JA; Takala, J; Uusaro, A; Walley, KR | 1 |
Bombardini, T; Borghi, B; Fedriga, P; Gaggini, G; Garberoglio, B; Marcelli, E; Picano, E; Plicchi, G | 1 |
Van Besouw, J | 1 |
Baer, F; de Roos, A; Fleck, E; Hundley, WG; Lorenz, C; Nagel, E; Neubauer, S; Pennell, DJ; Pettigrew, R; Sechtem, U; van der Wall, E; van Rossum, A; Wickline, S; Wilke, N | 1 |
Hayes, SN; McBride, P | 1 |
Abraham, WT; Adams, KF; Berkowitz, RL; Cheng, ML; Costanzo, MR; Fonarow, GC; LeJemtel, TH; Wynne, J | 1 |
Dec, GW | 1 |
Alexopoulos, GP; Anastasiou-Nana, MI; Kanakakis, J; Nanas, JN; Nanas, SN; Papazoglou, PD; Terrovitis, JV; Toumanidis, S; Tsagalou, EP; Tsolakis, EJ | 1 |
Dounis, V; Hansen, A; Malmberg, K; Rydén, L; Thrainsdottir, IS; Von Bibra, H | 1 |
Bax, JJ; Feringa, HH; Poldermans, D; Schouten, O | 1 |
Gehlen, H; Groner, U; Rohn, K; Stadler, P | 1 |
Aaronson, K; Frazier, OH; Mancini, D; Margulies, K; Maybaum, S; McRee, S; Miller, LW; Pagani, FD; Starling, RC; Torre-Amione, G; Xydas, S | 1 |
Gudur, MS; Kuiper, J; Mukkamala, R; Olivier, NB; Swamy, G | 1 |
Abraham, J; Champion, HC; Kapur, N; Kapur, NK; Klein, K; Mudd, JO; Wittstein, IS | 1 |
Esumi, G; Hara, T; Hikino, S; Hojo, S; Kinukawa, N; Masumoto, K; Nagata, K; Taguchi, T; Takahata, Y; Teshiba, R; Tsukimori, K; Wake, N | 1 |
Feigenbaum, H; Gradus-Pizlo, I; Kamalesh, M; Mahenthiran, J; Maskoun, W; Mustafa, N; Sawada, SG | 1 |
Bansal, M; Chan, J; Horowitz, J; Leano, R; Marwick, TH; Pillans, P | 1 |
Görges, M; Kück, K; Orr, JA; Westenskow, DR | 1 |
Elalmis, OA; Yenisehirli, A | 1 |
Booth, EA; Borzage, M; Friedlich, P; Nachar, RA; Seri, I; Soleymani, S; Wider, MD | 1 |
Aboukhoudir, F; Rekik, S | 1 |
Fleck, E; Gebker, R; Hucko, T; Jahnke, C; Kelle, S; Klein, C; Manka, R; Paetsch, I; Schnackenburg, B | 1 |
Ernst, FR; Gonzalez, L; Greenspan, J; Lasky, T | 1 |
Bonagura, JD; Li, X; Otoni, CC; Riesen, SC; Schober, KE; Smith, DN | 1 |
Eley, KA; Watt-Smith, SR; Young, JD | 1 |
Chłopicki, S; Drelicharz, L; Heinze-Paluchowska, S; Jabłońska, M; Skórka, T; Tyrankiewicz, U; Woźniak, M | 1 |
Cavusoglu, Y; Mert, U; Morrad, B; Mutlu, F; Nadir, A; Ulus, T | 1 |
Christensen, M; Connolly, S; Goday, PS; Manzi, J; Mikhailov, TA; Panchal, AK; Wakeham, M | 1 |
Boddu, SH; Churchwell, MD; Howard, MS; Mauro, VF | 1 |
Lim, SY; Morishita, K; Morita, T; Nakamura, K; Ohta, H; Osuga, T; Takiguchi, M; Yokoyama, N | 1 |
Abreu, J; Aguiar Rosa, S; Cacela, D; Cruz Ferreira, R; Fragata, J; Galrinho, A; Moura Branco, L; Portugal, G | 1 |
Amour, J; Apert-Verneuil, C; Bouabdallah, K; Carbognani, D; Cholley, B; Moyne, A; Nguyen, LS; Squara, P; Thierry, S | 1 |
Bakkehaug, JP; How, OJ; Kildal, AB; Myrmel, T; Rødland, L; Rønning, L | 1 |
Noguchi, M | 1 |
Abdul Ghaffar, Y; Feigenbaum, H; Maskoun, W; Mustafa, NG; Sawada, SG | 1 |
Arias Ortiz, J; De Backer, D; Levy, B | 1 |
Baran, DA; Blitzer, D; Copeland, H; Copeland, JG; Lirette, S | 1 |
Aydın, C; Kaplangoray, M | 1 |
Reviews
5 review(s) available for dobutamine and cardiovascular agents
Article | Year |
---|---|
Complications of pharmacologic stress echocardiography in coronary artery disease.
Topics: Adenosine; Cardiotonic Agents; Cardiovascular Agents; Coronary Disease; Dipyridamole; Dobutamine; Echocardiography; Exercise Test; Humans; Vasodilator Agents | 1996 |
[Postoperative cardiac care: theoretical use of various cardiovascular agents].
Topics: Cardiac Surgical Procedures; Cardiotonic Agents; Cardiovascular Agents; Dobutamine; Dopamine; Epinephrine; Humans; Isoproterenol; Postoperative Care; Vasoconstrictor Agents; Vasodilator Agents | 1985 |
[Anesthesia for heart transplantation].
Topics: Anesthesia, General; Animals; Cardiovascular Agents; Combined Modality Therapy; Dobutamine; Forecasting; Heart Failure; Heart Transplantation; Heart-Assist Devices; Hemodynamics; Humans; Phosphodiesterase Inhibitors; Preanesthetic Medication; Preoperative Care; Swine; Tissue and Organ Procurement; Transplantation, Heterologous; Transplantation, Homologous | 2001 |
Stress cardiovascular magnetic resonance: consensus panel report.
Topics: Adenosine; Cardiovascular Agents; Contrast Media; Coronary Artery Disease; Dipyridamole; Dobutamine; Exercise Test; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Monitoring, Physiologic; Myocardial Ischemia | 2001 |
The medical treatment of cardiogenic shock: cardiovascular drugs.
Topics: Cardiotonic Agents; Cardiovascular Agents; Dobutamine; Humans; Shock; Shock, Cardiogenic; Vasoconstrictor Agents | 2021 |
Trials
11 trial(s) available for dobutamine and cardiovascular agents
Article | Year |
---|---|
Changes in diastolic time with various pharmacologic agents: implication for myocardial perfusion.
Topics: Administration, Oral; Adolescent; Adult; Cardiovascular Agents; Clinical Trials as Topic; Coronary Circulation; Deslanoside; Diastole; Dobutamine; Heart Rate; Humans; Infusions, Parenteral; Injections, Intravenous; Isoproterenol; Lidocaine; Male; Myocardial Contraction; Propranolol; Time Factors | 1979 |
[Improvement of postinfarct left myocardial contractile function after administration of diltiazem].
Topics: Adult; Calcium Channel Blockers; Cardiovascular Agents; Diltiazem; Dobutamine; Echocardiography; Female; Humans; Injections, Intravenous; Male; Middle Aged; Myocardial Contraction; Myocardial Infarction; Ventricular Function, Left | 1998 |
Effects of dobutamine on coronary stenosis physiology and morphology: comparison with intracoronary adenosine.
Topics: Adenosine; Cardiac Catheterization; Cardiovascular Agents; Coronary Disease; Dobutamine; Female; Hemodynamics; Humans; Male; Middle Aged; Pericardium; Radiography | 1999 |
High vancomycin dosage regimens required by intensive care unit patients cotreated with drugs to improve haemodynamics following cardiac surgical procedures.
Topics: Anti-Bacterial Agents; Bayes Theorem; Cardiac Surgical Procedures; Cardiotonic Agents; Cardiovascular Agents; Creatinine; Critical Care; Diuretics; Dobutamine; Dopamine; Drug Interactions; Female; Furosemide; Hemodynamics; Humans; Intensive Care Units; Male; Middle Aged; Postoperative Care; Retrospective Studies; Vancomycin | 2000 |
Reverse left ventricular remodeling by intermittent dobutamine infusions and amiodarone in end-stage heart failure due to idiopathic dilated cardiomyopathy.
Topics: Administration, Oral; Adult; Aged; Amiodarone; Cardiomyopathy, Dilated; Cardiovascular Agents; Dobutamine; Female; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Prospective Studies; Stroke Volume; Ventricular Remodeling | 2006 |
Protecting the heart with cardiac medication in patients with left ventricular dysfunction undergoing major noncardiac vascular surgery.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Aged; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Cardiovascular Agents; Dobutamine; Echocardiography; Endpoint Determination; Female; Heart Diseases; Hospital Mortality; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Intraoperative Complications; Male; Middle Aged; Vascular Surgical Procedures; Ventricular Dysfunction, Left | 2006 |
Cardiac improvement during mechanical circulatory support: a prospective multicenter study of the LVAD Working Group.
Topics: Cardiovascular Agents; Combined Modality Therapy; Cytokines; Dobutamine; Exercise Test; Exercise Tolerance; Female; Fibrosis; Heart Failure; Heart Function Tests; Heart Transplantation; Heart-Assist Devices; Humans; Hypertrophy; Male; Middle Aged; Myocardium; Myocytes, Cardiac; Prospective Studies; Single-Blind Method; Stroke Volume; Treatment Outcome; Ultrasonography | 2007 |
Effects of perhexiline on myocardial deformation in patients with ischaemic left ventricular dysfunction.
Topics: Aged; Cardiotonic Agents; Cardiovascular Agents; Dobutamine; Echocardiography; Exercise Test; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Perhexiline; Placebos; Treatment Failure; Ventricular Dysfunction, Left; Ventricular Function, Left | 2010 |
Epinephrine, norepinephrine, dobutamine, and dopexamine effects on free flap skin blood flow.
Topics: Adult; Aged; Cardiovascular Agents; Dobutamine; Dopamine; Dose-Response Relationship, Drug; Epinephrine; Free Tissue Flaps; Head and Neck Neoplasms; Humans; Microcirculation; Middle Aged; Norepinephrine; Regional Blood Flow; Skin; Skin Transplantation; Sympathomimetics | 2012 |
Ivabradine treatment prevents dobutamine-induced increase in heart rate in patients with acute decompensated heart failure.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Benzazepines; Cardiotonic Agents; Cardiovascular Agents; Dobutamine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Electrocardiography, Ambulatory; Female; Heart Failure; Heart Rate; Humans; Ivabradine; Male; Middle Aged | 2015 |
Intravenous ivabradine versus placebo in patients with low cardiac output syndrome treated by dobutamine after elective coronary artery bypass surgery: a phase 2 exploratory randomized controlled trial.
Topics: Administration, Intravenous; Aged; Cardiac Output, Low; Cardiotonic Agents; Cardiovascular Agents; Coronary Artery Bypass; Dobutamine; Elective Surgical Procedures; Female; Humans; Ivabradine; Male; Middle Aged; Placebos; Single-Blind Method | 2018 |
Other Studies
43 other study(ies) available for dobutamine and cardiovascular agents
Article | Year |
---|---|
Enhancement of the force-frequency effect on myocardial contractility by adrenergic stimulation in conscious dogs.
Topics: Adrenergic beta-Agonists; Animals; Benzazepines; Cardiac Pacing, Artificial; Cardiovascular Agents; Consciousness; Dobutamine; Dogs; Female; Heart Rate; Male; Myocardial Contraction; Receptors, Adrenergic, beta; Ventricular Function, Left | 1992 |
Effects of cardiovascular drugs on oxygen consumption/oxygen delivery relationship in patients with congestive heart failure.
Topics: Acute Disease; Aged; Aged, 80 and over; Cardiovascular Agents; Catheterization, Swan-Ganz; Chronic Disease; Dobutamine; Enoximone; Female; Heart Failure; Hemodynamics; Humans; Imidazoles; Male; Middle Aged; Oxygen Consumption; Phosphodiesterase Inhibitors; Pulmonary Edema | 1992 |
Effects of vasoactive drugs on thromboxane A2 mimetic-induced pulmonary hypertension in newborn lambs.
Topics: Animals; Animals, Newborn; Cardiovascular Agents; Dobutamine; Dopamine; Hemodynamics; Hypertension, Pulmonary; Isoproterenol; Nitroprusside; Prostaglandin Endoperoxides, Synthetic; Sheep; Thromboxane A2 | 1991 |
[Computer-assisted regulation of blood pressure by drugs acting on the cardiovascular system. Problems in the development of a closed-loop control system].
Topics: Algorithms; Blood Pressure; Blood Pressure Determination; Cardiovascular Agents; Computers; Dobutamine; Dopamine; Humans; Infusion Pumps; Microcomputers; Norepinephrine; Software | 1986 |
Pharmacology and pharmacokinetics of drugs used to treat cardiac disease in horses.
Topics: Administration, Oral; Animals; Arrhythmias, Cardiac; Cardiovascular Agents; Digoxin; Diuretics; Dobutamine; Dopamine; Drug Administration Schedule; Edema; Heart Diseases; Heart Failure; Heart Rate; Hemodynamics; Horse Diseases; Horses; Injections, Intravenous; Lidocaine; Procainamide; Propranolol; Quinidine | 1985 |
Cardiogenic pulmonary edema.
Topics: Aminophylline; Cardiovascular Agents; Digoxin; Diuretics; Dobutamine; Dopamine; Heart Failure; Humans; Morphine; Nitroglycerin; Nitroprusside; Pulmonary Edema; Verapamil | 1984 |
Effect of dobutamine on cardiac function in man: reciprocal roles of heart rate and ventricular stroke volume.
Topics: Adult; Aged; Blood Pressure; Cardiac Output; Cardiovascular Agents; Catecholamines; Clonidine; Dobutamine; Drug Interactions; Heart Rate; Humans; Middle Aged; Stroke Volume; Surgical Procedures, Operative | 1982 |
Integrative cardiovascular actions of a novel catecholamine, GP-2-128.
Topics: Adrenergic beta-Antagonists; Animals; Benzamides; Cardiac Output; Cardiovascular Agents; Catecholamines; Dobutamine; Dogs; Female; Half-Life; Heart Rate; Hemodynamics; Injections, Intravenous; Iontophoresis; Isoproterenol; Male; Muscle Contraction; Myocardial Contraction; Stereoisomerism; Vascular Resistance | 1994 |
Interactions of a novel catecholamine, GP-2-128, with adrenoceptors.
Topics: Adipocytes; Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-2 Receptor Antagonists; Adrenergic Antagonists; Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-2 Receptor Antagonists; Animals; Aorta, Thoracic; Benzamides; Cardiovascular Agents; Catecholamines; Cricetinae; Dobutamine; Guinea Pigs; Ileum; In Vitro Techniques; Isoproterenol; Male; Muscle, Smooth, Vascular; Myocardial Contraction; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic; Receptors, Adrenergic, alpha-1; Receptors, Adrenergic, alpha-2; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Trachea | 1994 |
Pulmonary function tests in patients with congestive heart failure: effects of medical therapy.
Topics: Adult; Aged; Captopril; Cardiovascular Agents; Digoxin; Dobutamine; Drug Therapy, Combination; Echocardiography, Doppler; Forced Expiratory Volume; Furosemide; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Male; Middle Aged; Nitroglycerin; Nitroprusside; Vasodilator Agents; Vital Capacity | 1993 |
Zatebradine, a specific bradycardic agent, enhances the positive inotropic actions of dobutamine in ischemic myocardium.
Topics: Animals; Benzazepines; Cardiovascular Agents; Coronary Circulation; Dobutamine; Dogs; Drug Synergism; Female; Heart Rate; Hemodynamics; Male; Myocardial Contraction; Myocardial Ischemia; Stimulation, Chemical | 1994 |
Reversal of end-stage heart failure is predicted by long-term therapeutic response rather than initial hemodynamic and neurohormonal profile.
Topics: Adult; Cardiovascular Agents; Dobutamine; Dose-Response Relationship, Drug; Enalapril; Female; Follow-Up Studies; Furosemide; Heart Failure; Heart Transplantation; Hemodynamics; Humans; Isosorbide Dinitrate; Male; Middle Aged; Norepinephrine; Survival Rate; Treatment Outcome; Waiting Lists | 1996 |
Contractile versus microvascular reserve for the determination of the extent of myocardial salvage after reperfusion. The effect of residual coronary stenosis.
Topics: Adenosine; Animals; Cardiotonic Agents; Cardiovascular Agents; Contrast Media; Coronary Circulation; Coronary Disease; Dobutamine; Dogs; Echocardiography; Microcirculation; Myocardial Contraction; Myocardial Ischemia; Myocardial Reperfusion; Salvage Therapy | 1996 |
A model for the design and evaluation of algorithms for closed-loop cardiovascular therapy.
Topics: Algorithms; Cardiovascular Agents; Dobutamine; Dopamine; Drug Delivery Systems; Equipment Design; Models, Cardiovascular; Nitroglycerin; Nitroprusside; Nonlinear Dynamics; Pulsatile Flow | 1997 |
Right ventricular pressure and dilation during pressure overload determine dysfunction after pressure overload.
Topics: Animals; Atropine; Cardiac Catheterization; Cardiotonic Agents; Cardiovascular Agents; Diastole; Dilatation, Pathologic; Disease Models, Animal; Dobutamine; Female; Heart; Hemodynamics; Hexamethonium; Hypertension; Linear Models; Pericardium; Pulmonary Artery; Swine; Systole; Ventricular Dysfunction, Right | 2000 |
Gastric-arterial PCO2 gradient does not reflect systemic and splanchnic hemodynamics or oxygen transport after cardiac surgery.
Topics: Antihypertensive Agents; Arteries; Carbon Dioxide; Cardiovascular Agents; Catecholamines; Coronary Artery Bypass; Dobutamine; Dopamine; Enalapril; Gastric Mucosa; Hemodynamics; Histamine H2 Antagonists; Humans; Hydrogen-Ion Concentration; Hypertension; Nitroprusside; Oxygen; Oxygen Consumption; Partial Pressure; Postoperative Period; Splanchnic Circulation; Vasodilator Agents | 2000 |
Operator independent left ventricular function monitoring during pharmacological stress echo with the new peak transcutaneous acceleration signal.
Topics: Acceleration; Cardiovascular Agents; Dipyridamole; Dobutamine; Echocardiography; Electrocardiography; Exercise Test; Feasibility Studies; Heart Ventricles; Humans; Monitoring, Physiologic; Myocardial Contraction; Ventricular Function; Ventricular Function, Left | 2001 |
Diagnosing coronary heart disease: when to use stress imaging studies.
Topics: Adenosine; Cardiotonic Agents; Cardiovascular Agents; Coronary Angiography; Coronary Disease; Dipyridamole; Dobutamine; Echocardiography; Exercise Test; Family Practice; Female; Humans; Male; Middle Aged; Radionuclide Imaging; Referral and Consultation; Risk Factors; United States; Vasodilator Agents | 2003 |
In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE).
Topics: Acute Disease; Aged; Aged, 80 and over; Cardiovascular Agents; Dobutamine; Female; Heart Failure; Hospital Mortality; Humans; Infusions, Intravenous; Male; Middle Aged; Milrinone; Natriuretic Peptide, Brain; Nitroglycerin; Retrospective Studies | 2005 |
Acute decompensated heart failure: the shrinking role of inotropic therapy.
Topics: Acute Disease; Cardiovascular Agents; Dobutamine; Heart Failure; Humans; Milrinone; Natriuretic Peptide, Brain; Nitroglycerin; Treatment Outcome | 2005 |
Tissue Doppler imaging for the detection and quantitation of myocardial dysfunction in patients with type 2 diabetes mellitus.
Topics: Age Factors; Aged; Cardiomyopathies; Cardiovascular Agents; Diabetes Mellitus, Type 2; Diastole; Dipyridamole; Dobutamine; Echocardiography, Doppler, Pulsed; Echocardiography, Stress; Female; Humans; Male; Middle Aged; Myocardial Contraction; Systole | 2005 |
[Pulmonary artery wedge pressure and heart rate measurement during pharmacological stress induction for left cardial function diagnosis in horses with and without heart disease].
Topics: Animals; Atropine; Cardiovascular Agents; Case-Control Studies; Dobutamine; Echocardiography; Female; Heart Diseases; Heart Rate; Horse Diseases; Horses; Male; Parasympatholytics; Pulmonary Wedge Pressure; Stress, Physiological; Sympathomimetics; Time Factors | 2006 |
Continuous left ventricular ejection fraction monitoring by aortic pressure waveform analysis.
Topics: Animals; Aorta, Thoracic; Aortic Valve; Blood Pressure Determination; Cardiac Output; Cardiovascular Agents; Dobutamine; Dogs; Echocardiography; Elasticity Imaging Techniques; Electrocardiography; Models, Cardiovascular; Nitroprusside; Phenylephrine; Propanolamines; Stroke Volume; Ventricular Function, Left; Verapamil | 2009 |
Stress cardiomyopathy after intravenous administration of catecholamines and beta-receptor agonists.
Topics: Adrenergic beta-Agonists; Adult; Cardiomyopathies; Cardiovascular Agents; Catecholamines; Dobutamine; Epinephrine; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Ventricular Dysfunction, Left | 2009 |
Improvement in the outcome of patients with antenatally diagnosed congenital diaphragmatic hernia using gentle ventilation and circulatory stabilization.
Topics: Cardiovascular Agents; Cardiovascular System; Dobutamine; Dopamine; Female; Hernia, Diaphragmatic; Hernias, Diaphragmatic, Congenital; Humans; Infant, Newborn; Pregnancy; Respiration, Artificial; Treatment Outcome; Ultrasonography, Prenatal | 2009 |
Wall motion abnormalities with low-dose dobutamine predict a high risk of cardiac death in medically treated patients with ischemic cardiomyopathy.
Topics: Aged; Cardiomyopathies; Cardiovascular Agents; Dobutamine; Echocardiography, Stress; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Ischemia; Predictive Value of Tests; Proportional Hazards Models; Retrospective Studies; Risk Assessment; Risk Factors; Severity of Illness Index; Stroke Volume; Time Factors; Treatment Outcome; Ventricular Dysfunction, Left | 2009 |
A tool predicting future mean arterial blood pressure values improves the titration of vasoactive drugs.
Topics: Adult; Algorithms; Blood Pressure; Cardiovascular Agents; Computer Simulation; Dobutamine; Dopamine; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Models, Cardiovascular; Nitroprusside; Software | 2010 |
Dobutamine-induced spontaneous rhythmic contractions of human isolated atrial strips mimic physiological responses of intact human heart.
Topics: Cardiotonic Agents; Cardiovascular Agents; Dobutamine; Heart Atria; Heart Rate; Humans; Models, Biological; Myocardial Contraction; Reproducibility of Results | 2010 |
Dose-dependent hemodynamic and metabolic effects of vasoactive medications in normotensive, anesthetized neonatal piglets.
Topics: Animals; Animals, Newborn; Cardiovascular Agents; Carotid Artery, Common; Dobutamine; Dopamine; Dose-Response Relationship, Drug; Epinephrine; Hemodynamics; Hydrogen-Ion Concentration; Intestines; Kidney; Muscle, Skeletal; Norepinephrine; Oxygen; Regional Blood Flow; Spectroscopy, Near-Infrared; Swine; Water-Electrolyte Balance | 2011 |
Left ventricular systolic function deterioration during dobutamine stress echocardiography as an early manifestation of diabetic cardiomyopathy and reversal by optimized therapeutic approach.
Topics: Adrenergic Agonists; Adult; Aged; Aged, 80 and over; Biomarkers; Cardiovascular Agents; Diabetes Mellitus, Type 2; Diabetic Cardiomyopathies; Dobutamine; Echocardiography, Stress; Female; France; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Male; Middle Aged; Predictive Value of Tests; Prevalence; Prospective Studies; Stroke Volume; Systole; Treatment Outcome; Ventricular Dysfunction, Left; Ventricular Function, Left | 2012 |
The role of dobutamine stress cardiovascular magnetic resonance in the clinical management of patients with suspected and known coronary artery disease.
Topics: Aged; Cardiotonic Agents; Cardiovascular Agents; Chi-Square Distribution; Coronary Angiography; Coronary Artery Disease; Disease Progression; Disease-Free Survival; Dobutamine; Female; Germany; Humans; Kaplan-Meier Estimate; Magnetic Resonance Imaging, Cine; Male; Middle Aged; Patient Selection; Predictive Value of Tests; Prognosis; Prospective Studies; Risk Assessment; Risk Factors; Time Factors | 2011 |
Dopamine and dobutamine use in preterm or low birth weight neonates in the premier 2008 database.
Topics: Cardiovascular Agents; Cardiovascular Diseases; Chi-Square Distribution; Databases as Topic; Dobutamine; Dopamine; Drug Utilization; Female; Humans; Infant Mortality; Infant, Low Birth Weight; Infant, Newborn; Infant, Premature; Male; Practice Patterns, Physicians'; Proportional Hazards Models; Retrospective Studies; Risk Assessment; Risk Factors; Treatment Outcome | 2011 |
Effects of ivabradine on heart rate and left ventricular function in healthy cats and cats with hypertrophic cardiomyopathy.
Topics: Adrenergic beta-1 Receptor Agonists; Adrenergic beta-1 Receptor Antagonists; Animals; Benzazepines; Blood Pressure; Cardiomyopathy, Hypertrophic; Cardiovascular Agents; Cat Diseases; Cats; Dobutamine; Dose-Response Relationship, Drug; Heart Rate; Ivabradine; Propanolamines; Ventricular Function, Left | 2012 |
The effect of the renin-angiotensin-aldosterone system inhibition on myocardial function in early and late phases of dilated cardiomyopathy in Tgaq*44 mice.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Canrenone; Cardiovascular Agents; Dobutamine; Heart Failure; Mice; Mice, Transgenic; Models, Animal; Perindopril; Renin-Angiotensin System | 2013 |
Safety of Enteral Feedings in Critically Ill Children Receiving Vasoactive Agents.
Topics: Adolescent; Cardiovascular Agents; Child; Child, Preschool; Critical Illness; Dobutamine; Dopamine; Enteral Nutrition; Epinephrine; Female; Gastrointestinal Tract; Humans; Infant; Intensive Care Units, Pediatric; Length of Stay; Logistic Models; Male; Milrinone; Norepinephrine; Retrospective Studies; Vasopressins | 2016 |
Compatibility of conivaptan injection with select cardiovascular medications.
Topics: Benzazepines; Cardiovascular Agents; Contraindications; Dobutamine; Dopamine; Drug Combinations; Drug Incompatibility; Humans; Infusions, Intravenous; Milrinone; Nitroglycerin | 2014 |
Effects of various cardiovascular drugs on indices obtained with two-dimensional speckle tracking echocardiography of the left atrium and time-left atrial area curve analysis in healthy dogs.
Topics: Animals; Area Under Curve; Atrial Function, Left; Cardiovascular Agents; Dobutamine; Dogs; Echocardiography; Female; Male; Milrinone; Phenylephrine; Propanolamines | 2015 |
Contribution of Dobutamine Stress Echocardiography to the Diagnosis and Prognosis of Low-Flow/Low-Gradient Aortic Stenosis.
Topics: Adrenergic beta-1 Receptor Agonists; Aged; Aged, 80 and over; Aortic Valve; Aortic Valve Stenosis; Cardiovascular Agents; Dobutamine; Echocardiography, Doppler; Echocardiography, Stress; Female; Heart Valve Prosthesis Implantation; Hemodynamics; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Predictive Value of Tests; Proportional Hazards Models; Retrospective Studies; Risk Factors; Severity of Illness Index; Stroke Volume; Time Factors; Transcatheter Aortic Valve Replacement; Treatment Outcome; Ventricular Function, Left | 2016 |
Opposite diastolic effects of omecamtiv mecarbil versus dobutamine and ivabradine co-treatment in pigs with acute ischemic heart failure.
Topics: Animals; Cardiotonic Agents; Cardiovascular Agents; Diastole; Dobutamine; Drug Therapy, Combination; Heart Failure; Ivabradine; Male; Myocardial Ischemia; Swine; Treatment Outcome; Urea | 2018 |
[Inotropic agents (Dopamine, Dobutamine, PDE inhibitor)].
Topics: Cardiovascular Agents; Dobutamine; Dopamine; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases | 2016 |
Low dose wall motion score predicts the short and long-term benefit of surgical revascularization in patients with ischemic left ventricular dysfunction.
Topics: Aged; Cardiomyopathies; Cardiotonic Agents; Cardiovascular Agents; Clinical Decision-Making; Coronary Artery Bypass; Dobutamine; Echocardiography, Stress; Female; Humans; Male; Middle Aged; Myocardial Ischemia; Myocardium; Patient Selection; Predictive Value of Tests; Recovery of Function; Retrospective Studies; Risk Factors; Stroke Volume; Time Factors; Tissue Survival; Treatment Outcome; Ventricular Dysfunction, Left; Ventricular Function, Left | 2019 |
Does donor treatment with inotropes and/or vasopressors impact post-transplant outcomes?
Topics: Adult; Cardiovascular Agents; Dobutamine; Dopamine; Epinephrine; Female; Graft Survival; Heart Transplantation; Humans; Male; Norepinephrine; Phenylephrine; Tissue and Organ Procurement; Tissue Donors; Vasoconstrictor Agents | 2023 |
[Comparative assessment of the effects of dobutamine and levosimendan on right ventricular ejection fraction in patients with biventricular heart failure].
Topics: Cardiovascular Agents; Cross-Sectional Studies; Dobutamine; Heart Failure; Humans; Prospective Studies; Simendan; Stroke Volume; Ventricular Function, Left; Ventricular Function, Right | 2023 |